We currently don't have sufficient analyst coverage to forecast growth and revenue for Active Fine Chemicals.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth
16.3%
Revenue growth rate
n/a
Future return on equity
n/a
Analyst coverage
None
Last updated
n/a
Recent future growth updates
No updates
Recent updates
In this section we usually present revenue and earnings growth
projections based on the consensus estimates of professional
analysts to help investors understand the company’s ability to
generate profit. But as Active Fine Chemicals has not provided enough
past data and has no analyst forecast, its future earnings
cannot be reliably calculated by extrapolating past data or
using analyst predictions.
This is quite a rare situation as 97% of companies covered by
SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
DSE:ACTIVEFINE - Analysts future estimates and past financials data (BDT Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2023
1,352
-5
-279
98
N/A
12/31/2022
1,443
1
-228
130
N/A
9/30/2022
1,523
-25
-91
194
N/A
6/30/2022
1,672
26
164
372
N/A
3/31/2022
1,699
55
-6
112
N/A
12/31/2021
1,828
53
-271
-153
N/A
9/30/2021
1,853
94
-444
-28
N/A
6/30/2021
1,821
38
-761
-183
N/A
3/31/2021
1,383
-245
-380
92
N/A
12/31/2020
1,201
-206
-1,208
287
N/A
9/30/2020
1,206
-157
-1,300
41
N/A
6/30/2020
1,308
-56
-852
574
N/A
3/31/2020
1,776
377
-1,287
422
N/A
12/31/2019
2,115
541
-352
839
N/A
9/30/2019
2,346
671
-135
1,217
N/A
6/30/2019
2,419
712
-513
962
N/A
3/31/2019
2,308
989
-290
1,089
N/A
12/31/2018
2,224
915
-309
950
N/A
9/30/2018
2,173
846
-460
905
N/A
6/30/2018
2,156
825
-529
710
N/A
3/31/2018
2,272
548
-440
923
N/A
12/31/2017
2,225
556
-531
828
N/A
9/30/2017
2,179
558
-254
771
N/A
6/30/2017
2,129
554
-157
885
N/A
3/31/2017
1,896
486
-83
796
N/A
12/31/2016
1,837
459
N/A
786
N/A
9/30/2016
1,810
457
N/A
816
N/A
6/30/2016
1,894
481
N/A
551
N/A
9/30/2015
1,665
457
N/A
179
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ACTIVEFINE's forecast earnings growth is above the savings rate (4.2%).
Earnings vs Market: Insufficient data to determine if ACTIVEFINE's earnings are forecast to grow faster than the BD market
High Growth Earnings: Insufficient data to determine if ACTIVEFINE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ACTIVEFINE's revenue is forecast to grow faster than the BD market.
High Growth Revenue: Insufficient data to determine if ACTIVEFINE's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ACTIVEFINE's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/06 10:54
End of Day Share Price
2026/07/06 00:00
Earnings
2023/03/31
Annual Earnings
2022/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Active Fine Chemicals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.